{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:22:59Z","timestamp":1790666579984,"version":"4.1.0"},"reference-count":56,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2025.2000","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T11:41:33Z","timestamp":1747827693000},"page":"1-8","source":"Crossref","is-referenced-by-count":3,"title":["Thrombotic and cardiovascular events in HIV infection (Review)"],"prefix":"10.3892","volume":"23","author":[{"given":"Georgios","family":"Dryllis","sequence":"first","affiliation":[{"name":"Laboratory of Reliability and Quality Control in Laboratory Hematology, Department of Biomedical Sciences, School of Health and Caring Sciences, University of West Attica, 12243 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mavra","family":"Vasilopoulou","sequence":"additional","affiliation":[{"name":"Hemorrhage\u2011Thrombosis-Transfusion Medicine, Department of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Politou","sequence":"additional","affiliation":[{"name":"Hematology Laboratory\u2011Blood Bank, Aretaieion Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilleas","family":"Gerogkiokas","sequence":"additional","affiliation":[{"name":"Hematology Laboratory\u2011Blood Bank, Aretaieion Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Pittaras","sequence":"additional","affiliation":[{"name":"Hematology Laboratory\u2011Blood Bank, Aretaieion Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Zoumpourlis","sequence":"additional","affiliation":[{"name":"Biomedical Applications Unit, Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, Medical School, University of Crete, 71500 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyri","family":"Gialeraki","sequence":"additional","affiliation":[{"name":"Hematology Laboratory-Blood Bank, ATTIKON Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"key20250611120302_b1-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20250611120302_b2-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","article-title":"Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras","volume":"41","author":"Crum","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20250611120302_b3-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/10408363.2013.865702","article-title":"Role of inflammation in HIV-1 disease progression and prognosis","volume":"51","author":"Ipp","year":"2014","journal-title":"Crit Rev Clin Lab Sci"},{"key":"key20250611120302_b4-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: Causes and consequences","volume":"214","author":"Appay","year":"2008","journal-title":"J Pathol"},{"key":"key20250611120302_b5-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"key20250611120302_b6-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.smim.2016.10.010","article-title":"Blood coagulation in immunothrombosis-At the frontline of intravascular immunity","volume":"28","author":"Gaertner","year":"2016","journal-title":"Semin Immunol"},{"key":"key20250611120302_b7-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/09537104.2020.1817360","article-title":"Immunothrombosis and thromboinflammation in host defense and disease","volume":"32","author":"Martinod","year":"2021","journal-title":"Platelets"},{"key":"key20250611120302_b8-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.thromres.2011.11.022","article-title":"Endothelial and platelet function alterations in HIV-infected patients","volume":"129","author":"Gresele","year":"2012","journal-title":"Thromb Res"},{"issue":"1608","key":"key20250611120302_b9-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.3390\/biom13111608","article-title":"Platelet and HIV interactions and their contribution to non-AIDS comorbidities","volume":"13","author":"Awamura","year":"2023","journal-title":"Biomolecules"},{"key":"key20250611120302_b10-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/s-0038-1676374","article-title":"Pathological clotting and deep vein thrombosis in patients with HIV","volume":"45","author":"Jackson","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"key20250611120302_b11-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","article-title":"Increased tissue factor expression on circulating monocytes in chronic HIV infection: Relationship to in vivo coagulation and immune activation","volume":"115","author":"Funderburg","year":"2010","journal-title":"Blood"},{"key":"key20250611120302_b12-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.thromres.2018.08.005","article-title":"The role of neutrophils in thrombosis","volume":"170","author":"Kapoor","year":"2018","journal-title":"Thromb Res"},{"issue":"e2011030","key":"key20250611120302_b13-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2011.030","article-title":"HIV-associated venous thromboembolism","volume":"3","author":"Bibas","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"key20250611120302_b14-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11904-012-0118-8","article-title":"HIV and inflammation: Mechanisms and consequences","volume":"9","author":"Hunt","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1940","key":"key20250611120302_b15-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031940","article-title":"Gut microbiota-derived TMAO: A causal factor promoting atherosclerotic cardiovascular disease?","volume":"24","author":"Canyelles","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20250611120302_b16-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cmet.2024.01.014","article-title":"Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin \u03b12\u03b21","volume":"36","author":"Huang","year":"2024","journal-title":"Cell Metab"},{"key":"key20250611120302_b17-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/ATVBAHA.121.317276","article-title":"Gut microbiota, plasma metabolomic profiles, and carotid artery atherosclerosis in HIV infection","volume":"42","author":"Wang","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"357","key":"key20250611120302_b18-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01801-9","article-title":"Platelet activation in adult HIV-infected patients on antiretroviral therapy: A systematic review and meta-analysis","volume":"18","author":"Nkambule","year":"2020","journal-title":"BMC Med"},{"issue":"14999","key":"key20250611120302_b19-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33403-0","article-title":"Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals","volume":"8","author":"Mesquita","year":"2018","journal-title":"Sci Rep"},{"issue":"e0130061","key":"key20250611120302_b20-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130061","article-title":"Platelet activation in human immunodeficiency virus type-1 patients is not altered with cocaine abuse","volume":"10","author":"Kiebala","year":"2015","journal-title":"PLoS One"},{"key":"key20250611120302_b21-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/hiv.12270","article-title":"The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection","volume":"16","author":"O'Halloran","year":"2015","journal-title":"HIV Med"},{"issue":"eaam5441","key":"key20250611120302_b22-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam5441","article-title":"Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy","volume":"9","author":"Schechter","year":"2017","journal-title":"Sci Transl Med"},{"key":"key20250611120302_b23-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1097\/QAD.0000000000000415","article-title":"Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen","volume":"28","author":"Tunjungputri","year":"2014","journal-title":"AIDS"},{"key":"key20250611120302_b24-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/QAD.0000000000003373","article-title":"Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV","volume":"37","author":"Jaschinski","year":"2023","journal-title":"AIDS"},{"issue":"102654","key":"key20250611120302_b25-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102654","article-title":"Cardiovascular disease and its risk factors among people living with HIV: A systematic review and meta-analysis","volume":"18","author":"Du","year":"2025","journal-title":"J Infect Public Health"},{"key":"key20250611120302_b26-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/bph.16016","article-title":"Abacavir causes leukocyte\/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin-like oxidized low-density lipoprotein receptor-1","volume":"180","author":"Blanch-Ru\u00edz","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"1182942","key":"key20250611120302_b27-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1182942","article-title":"Abacavir use is associated with increased prothrombin conversion","volume":"14","author":"Yan","year":"2023","journal-title":"Front Immunol"},{"key":"key20250611120302_b28-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2352-3018(22)00094-7","article-title":"Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: A multicentre prospective study from the RESPOND cohort consortium","volume":"9","author":"Neesgaard","year":"2022","journal-title":"Lancet HIV"},{"key":"key20250611120302_b29-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.122.057443","article-title":"Cardiovascular disease among persons living with HIV: New insights into pathogenesis and clinical manifestations in a global context","volume":"147","author":"Ntsekhe","year":"2023","journal-title":"Circulation"},{"key":"key20250611120302_b30-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1055\/s-0032-1306434","article-title":"Venous and arterial thrombosis associated with HIV infection","volume":"38","author":"Dentali","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"key20250611120302_b31-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/00002030-200303280-00020","article-title":"Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy","volume":"17","author":"De Gaetano Donati","year":"2003","journal-title":"AIDS"},{"issue":"ofab439","key":"key20250611120302_b32-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab439","article-title":"Efficacy, safety, and durability of long-acting cabotegravir and rilpivirine in adults with human immunodeficiency virus type 1 infection: 5-Year results from the LATTE-2 study","volume":"8","author":"Smith","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"key20250611120302_b33-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"key20250611120302_b34-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00002030-200002180-00015","article-title":"Epidemiology of thrombosis in HIV-infected individuals. The adult\/adolescent spectrum of HIV disease project","volume":"14","author":"Sullivan","year":"2000","journal-title":"AIDS"},{"key":"key20250611120302_b35-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1468-1293.2010.00869.x","article-title":"HIV and risk of venous thromboembolism: A Danish nationwide population-based cohort study","volume":"12","author":"Rasmussen","year":"2011","journal-title":"HIV Med"},{"issue":"e1003101","key":"key20250611120302_b36-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003101","article-title":"Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study","volume":"17","author":"Rokx","year":"2020","journal-title":"PLoS Med"},{"key":"key20250611120302_b37-BR-23-1-02000","author":"Shaw"},{"key":"key20250611120302_b38-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2017.04.034","article-title":"Profile of 26 HIV seropositive individuals with cerebral venous thrombosis","volume":"378","author":"Netravathi","year":"2017","journal-title":"J Neurol Sci"},{"key":"key20250611120302_b39-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.revmed.2005.04.023","article-title":"Portal vein thrombosis in HIV-infected patients: Report of four cases","volume":"26","author":"Ramanampamonjy","year":"2005","journal-title":"Rev Med Interne"},{"key":"key20250611120302_b40-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: Systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"key20250611120302_b41-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/QAD.0b013e32835cae9c","article-title":"Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population","volume":"27","author":"Rodger","year":"2013","journal-title":"AIDS"},{"key":"key20250611120302_b42-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1161\/ATVBAHA.122.318232","article-title":"Cardiovascular disease and thrombosis in HIV infection","volume":"43","author":"Perkins","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20250611120302_b43-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","article-title":"Relative risk of cardiovascular disease among people living with HIV: A systematic review and meta-analysis","volume":"13","author":"Islam","year":"2012","journal-title":"HIV Med"},{"issue":"e0176686","key":"key20250611120302_b44-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176686","article-title":"HIV infection as vascular risk: A systematic review of the literature and meta-analysis","volume":"12","author":"Gutierrez","year":"2017","journal-title":"PLoS One"},{"issue":"e025874","key":"key20250611120302_b45-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025874","article-title":"Risk of myocardial infarction among people living with HIV: An updated systematic review and meta-analysis","volume":"9","author":"Eyawo","year":"2019","journal-title":"BMJ Open"},{"key":"key20250611120302_b46-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/archneur.1997.00550210078016","article-title":"Human immunodeficiency virus infection and stroke in young patients","volume":"54","author":"Qureshi","year":"1997","journal-title":"Arch Neurol"},{"key":"key20250611120302_b47-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cjca.2018.11.032","article-title":"Stroke in HIV","volume":"35","author":"Bogorodskaya","year":"2019","journal-title":"Can J Cardiol"},{"key":"key20250611120302_b48-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1097\/QAD.0000000000000452","article-title":"Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection","volume":"28","author":"Chow","year":"2014","journal-title":"AIDS"},{"key":"key20250611120302_b49-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"S267","DOI":"10.1086\/422363","article-title":"HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: An observational study","volume":"39 (Suppl 5)","author":"Becker","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"35","key":"key20250611120302_b50-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-018-0189-x","article-title":"Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era","volume":"16","author":"Louw","year":"2018","journal-title":"Thromb J"},{"key":"key20250611120302_b51-BR-23-1-02000","doi-asserted-by":"crossref","first-page":"89","DOI":"10.17925\/EOH.2012.08.02.89","article-title":"HIV-associated thrombotic thrombocytopenic purpura-what we know so far","volume":"8","author":"Meiring","year":"2012","journal-title":"Eur Oncol Haematol"},{"key":"key20250611120302_b52-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1086\/522761","article-title":"HIV infection increases the risk of heparin-induced thrombocytopenia","volume":"45","author":"Thompson","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"590","key":"key20250611120302_b53-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.3390\/v14030590","article-title":"Elevated risk of venous thromboembolism in people living with HIV","volume":"14","author":"Zhang","year":"2022","journal-title":"Viruses"},{"key":"key20250611120302_b54-BR-23-1-02000","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"key20250611120302_b55-BR-23-1-02000","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"issue":"70","key":"key20250611120302_b56-BR-23-1-02000","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02163-6","article-title":"Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes","volume":"22","author":"Gabay","year":"2020","journal-title":"Arthritis Res Ther"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:03:21Z","timestamp":1749632601000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2025.2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,21]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2025.2000","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]}}}